Polypharmacy and Deprescribing in Older Adults
Older adults commonly end up on many medications. Deprescribing is an important part of individualizing care for older adults. It is an opportunity to discuss treatment options and revisit medications that may not have been reassessed in many years. A large evidence base exists in the field, suggesting that deprescribing is feasible and safe, though questions remain about the potential clinical benefits. Deprescribing research faces a myriad of challenges, such as identifying and employing the optimal outcome measures. Further, there is uncertainty about which deprescribing approaches are likely to be most effective and in what contexts. Evidence on barriers and facilitators to deprescribing has underscored how deprescribing in routine clinical practice can be complex and challenging. Thus, finding practical, sustainable ways to implement deprescribing is a priority for future research in the field.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Annual review of medicine - 75(2024) vom: 29. Jan., Seite 113-127 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thompson, Wade [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Deprescribing |
|---|
| Anmerkungen: |
Date Completed 30.01.2024 Date Revised 30.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1146/annurev-med-070822-101947 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362258244 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362258244 | ||
| 003 | DE-627 | ||
| 005 | 20240130232034.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1146/annurev-med-070822-101947 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1275.xml |
| 035 | |a (DE-627)NLM362258244 | ||
| 035 | |a (NLM)37729029 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thompson, Wade |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Polypharmacy and Deprescribing in Older Adults |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.01.2024 | ||
| 500 | |a Date Revised 30.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Older adults commonly end up on many medications. Deprescribing is an important part of individualizing care for older adults. It is an opportunity to discuss treatment options and revisit medications that may not have been reassessed in many years. A large evidence base exists in the field, suggesting that deprescribing is feasible and safe, though questions remain about the potential clinical benefits. Deprescribing research faces a myriad of challenges, such as identifying and employing the optimal outcome measures. Further, there is uncertainty about which deprescribing approaches are likely to be most effective and in what contexts. Evidence on barriers and facilitators to deprescribing has underscored how deprescribing in routine clinical practice can be complex and challenging. Thus, finding practical, sustainable ways to implement deprescribing is a priority for future research in the field | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a deprescribing | |
| 650 | 4 | |a medication appropriateness | |
| 650 | 4 | |a medication overload | |
| 650 | 4 | |a medication safety | |
| 650 | 4 | |a older adults | |
| 650 | 4 | |a polypharmacy | |
| 650 | 4 | |a prescribing | |
| 700 | 1 | |a McDonald, Emily G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annual review of medicine |d 1950 |g 75(2024) vom: 29. Jan., Seite 113-127 |w (DE-627)NLM00007831X |x 1545-326X |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2024 |g day:29 |g month:01 |g pages:113-127 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1146/annurev-med-070822-101947 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2024 |b 29 |c 01 |h 113-127 | ||